{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:41:09Z","timestamp":1772750469896,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.humimm.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,10,13]],"date-time":"2012-10-13T20:35:25Z","timestamp":1350160525000},"page":"75-81","source":"Crossref","is-referenced-by-count":18,"title":["Threshold serum concentrations of tumour necrosis factor alpha (TNF\u03b1) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)"],"prefix":"10.1016","volume":"74","author":[{"given":"Katarzyna","family":"Zorena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Kula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Raczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Raczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2012.10.002_b0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00125-010-1993-4","article-title":"Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025","volume":"54","author":"Jarosz-Chobot","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2012.10.002_b0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1464-5491.2009.02737.x","article-title":"Australia\u2019s national trends in the incidence of Type 1 diabetes in 0\u201314-year-olds, 2000\u20132006","volume":"26","author":"Catanzariti","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.humimm.2012.10.002_b0015","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"EURODIAB study group. Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2012.10.002_b0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1399-5448.2011.00762.x","article-title":"Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006","volume":"12","author":"Cho","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.humimm.2012.10.002_b0025","first-page":"708","article-title":"Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995\u20132008","volume":"106","author":"Kumar","year":"2008","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.humimm.2012.10.002_b0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bmj.39478.378241.BE","article-title":"Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study","volume":"336","author":"Amin","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.humimm.2012.10.002_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-5448.2009.00576.x","article-title":"Microvascular and macrovascular complications associated with diabetes in children and adolescents. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium","volume":"12","author":"Donaghue","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.humimm.2012.10.002_b0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","article-title":"Prevention of diabetic renal disease with special reference to microalbuminuria","volume":"346","author":"Mogensen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2012.10.002_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdiacomp.2006.04.001","article-title":"Renal and retinal microangiopathy after 15years of follow-up study in a sample of type 1 diabetes mellitus patients","volume":"21","author":"Romero","year":"2007","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.humimm.2012.10.002_b0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2337\/dc11-1489","article-title":"Diabetes study group of the Italian society of paediatric endocrinology and diabetology. Infant and toddler type 1 diabetes: complications after 20years\u2019 duration","volume":"35","author":"Salardi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.humimm.2012.10.002_b0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00125-005-0082-6","article-title":"Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway","volume":"49","author":"Skrivarhaug","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2012.10.002_b0060","doi-asserted-by":"crossref","unstructured":"Gomes MB, de Mattos Matheus AS, Calliari LE, Luescher JL, Manna TD, Savoldelli RD, Cobas RA, Coelho WS, Tschiedel B, Ramos AJ, Fonseca RM, Araujo NB, Almeida HG, Melo NH, Jezini DL, Negrato CA. Economic status and clinical care in young type 1 diabetes patients: a nationwide multicenter study in Brazil. Acta Diabetol 2012 [Epub ahead of print].","DOI":"10.1007\/s00592-012-0404-3"},{"key":"10.1016\/j.humimm.2012.10.002_b0065","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00125-011-2176-7","article-title":"Scottish diabetes research network epidemiology group. Inpatient costs for people with type 1 and type 2 diabetes in scotland: a study from the scottish diabetes research network epidemiology group","volume":"54","author":"Govan","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2012.10.002_b0070","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1542\/peds.2004-2127","article-title":"Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health","volume":"115","author":"Griebsch","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.humimm.2012.10.002_b0075","first-page":"9","article-title":"A cost-effectiveness analysis of treatment of diabetic complications in 2002","volume":"1","author":"Kawalec","year":"2004","journal-title":"J Diabetes Poland"},{"key":"10.1016\/j.humimm.2012.10.002_b0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0161-6420(93)31562-9","article-title":"The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy","volume":"100","author":"Cruickshanks","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.humimm.2012.10.002_b0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2337\/dc11-1177","article-title":"Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes","volume":"35","author":"Benitez-Aguirre","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.humimm.2012.10.002_b0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s001250051029","article-title":"Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM","volume":"41","author":"Berg","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2012.10.002_b0095","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2337\/diabetes.44.7.824","article-title":"Formation of immunochemical advanced glycosylation end-products precedes and correlates with early manifestations of renal and retinal disease in diabetes","volume":"44","author":"Beisswenger","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.humimm.2012.10.002_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/92196","article-title":"Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children","author":"Zorena","year":"2007","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.humimm.2012.10.002_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2007.07.011","article-title":"The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy","volume":"79","author":"My\u015bliwiec","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.humimm.2012.10.002_b0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-3083.2007.02054.x","article-title":"Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus","volume":"67","author":"Zorena","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.humimm.2012.10.002_b0115","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/jama.288.20.2579","article-title":"Molecular understanding of hyperglycemia\u00b4s adverse effects for diabetic complications","volume":"288","author":"Sheetz","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2012.10.002_b0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.lfs.2004.09.011","article-title":"Advanced glycation and endothelial functions: a link towards vascular complications in diabetes","volume":"76","author":"Rojas","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.humimm.2012.10.002_b0125","doi-asserted-by":"crossref","unstructured":"DAgati V, Yan SF, Ramasamy R, Schmidt AM. RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells, Trends Endocrinol Metab 2010;21:50\u201356.","DOI":"10.1016\/j.tem.2009.07.003"},{"key":"10.1016\/j.humimm.2012.10.002_b0130","first-page":"190","article-title":"Endogenous secretory RAGE but not soluble RAGE is associated with caroid atherosclerosis in type 1 diabetes patients, Daibetes Vasc","volume":"5","author":"Katakami","year":"2001","journal-title":"Dis Res"},{"key":"10.1016\/j.humimm.2012.10.002_b0135","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","article-title":"RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice","volume":"106","author":"Bucciarelle","year":"2002","journal-title":"Criculation"},{"key":"10.1016\/j.humimm.2012.10.002_b0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/PL00013443","article-title":"Advanced glycation end products in adolescents and young adults with diabetic angiopathy","volume":"14","author":"Chiarelli","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.humimm.2012.10.002_b0145","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2337\/diacare.26.9.2609","article-title":"Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and epsilon-(carboxymethyl)lysine","volume":"26","author":"Galler","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.humimm.2012.10.002_b0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1515\/JPEM.2009.22.5.433","article-title":"HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus","volume":"22","author":"Kostolansk\u00e1","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.humimm.2012.10.002_b0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.humimm.2012.10.002_b0160","first-page":"A3","article-title":"Clinical recommendations for treatment of patients with diabetes","volume":"12","author":"Position of the Polish Diabetes Association","year":"2011","journal-title":"J Diabetes Poland"},{"key":"10.1016\/j.humimm.2012.10.002_b0165","doi-asserted-by":"crossref","unstructured":"ETDRS Rerearch Group, ETDRS Report No. 11. Classification of diabetic retinopathy from fluorescein angiograms. Ophthalmology 1991;98:807\u2013822.","DOI":"10.1016\/S0161-6420(13)38013-0"},{"key":"10.1016\/j.humimm.2012.10.002_b0170","doi-asserted-by":"crossref","unstructured":"24th Report. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescent. Pediatrics 2004;114:555\u2013576.","DOI":"10.1542\/peds.114.2.S2.555"},{"key":"10.1016\/j.humimm.2012.10.002_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.humimm.2012.10.002_b0180","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.humimm.2012.10.002_b0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/JPEM.2009.22.10.895","article-title":"Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus","volume":"22","author":"Dettoraki","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.humimm.2012.10.002_b0190","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.preteyeres.2008.09.002","article-title":"Vascular endothelial growth factor and diabetic complications","volume":"27","author":"Wirostko","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.humimm.2012.10.002_b0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2012.10.002_b0200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1464-5491.2000.00350.x","article-title":"Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications","volume":"17","author":"Chiarelli","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.humimm.2012.10.002_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/187221409788452381","article-title":"Modulatory factors responsible for neoangiogenesis in young patients with long-standing diabetes mellitus type 1. Recent","volume":"3","author":"Zorena","year":"2009","journal-title":"Patents Endocr Metabol Immun Drug Disc"},{"key":"10.1016\/j.humimm.2012.10.002_b0210","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jc.86.8.3871","article-title":"Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria","volume":"86","author":"Santilli","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humimm.2012.10.002_b0215","first-page":"2837","article-title":"Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof","volume":"87","author":"Zhu","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.humimm.2012.10.002_b0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/jhh.2008.105","article-title":"Microalbuminuria: do we need a new threshold?","volume":"23","author":"Zamora","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.humimm.2012.10.002_b0225","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1464-5491.2005.01527.x","article-title":"Prevalence of diabetes complications 6years after diagnosis in an incident cohort of childhood diabetes","volume":"22","author":"Donaghue","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.humimm.2012.10.002_b0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/187221307782418892","article-title":"The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults","volume":"1","author":"Krasny","year":"2007","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.humimm.2012.10.002_b0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1989.01070010243030","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. IX Four-year incidence and progression of diabetic retinopathy when age at diagnosis is <30years","volume":"107","author":"Klein","year":"1989","journal-title":"Arch Ophtalmol"},{"key":"10.1016\/j.humimm.2012.10.002_b0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1464-5491.2001.00484.x","article-title":"Wessex Diabetic Nephropathy Project Longitudinal study of urinary albumin excretion in young diabetic patients \u2013 Wessex Diabetic","volume":"18","author":"Twyman","year":"2001","journal-title":"Nephropathy Project. Diabet. Med."},{"key":"10.1016\/j.humimm.2012.10.002_b0245","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diacare.25.5.859","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study","volume":"25","author":"Rossing","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.humimm.2012.10.002_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jcla.20289","article-title":"Establishment of a cut-point value of serum TNF-alpha levels in the metabolic syndrome","volume":"23","author":"Gurrola-D\u00edaz","year":"2009","journal-title":"J Clin Lab Anal."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912005642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912005642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T05:54:07Z","timestamp":1542693247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885912005642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0198885912005642"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2012.10.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}